Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Immuneering (IMRX) Accumulated Depreciation & Amortization (2020 - 2026)

Immuneering's Accumulated Depreciation & Amortization history spans 7 years, with the latest figure at $81402.0 for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 4.53% to $81402.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $81402.0, a 4.53% decrease, with the full-year FY2025 number at $324517.0, down 8.79% from a year prior.
  • Accumulated Depreciation & Amortization came in at $81402.0 for Q1 2026, down from $324517.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $418337.0 in Q4 2022, with the low at $54560.0 in Q2 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $177269.6 across 5 years, with a median of $90209.0 in 2024.
  • Peak annual rise in Accumulated Depreciation & Amortization hit 242.36% in 2023, while the deepest fall reached 65.52% in 2023.
  • Year by year, Accumulated Depreciation & Amortization stood at $418337.0 in 2022, then decreased by 22.83% to $322816.0 in 2023, then rose by 10.22% to $355807.0 in 2024, then dropped by 8.79% to $324517.0 in 2025, then plummeted by 74.92% to $81402.0 in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for IMRX at $81402.0 in Q1 2026, $324517.0 in Q4 2025, and $248628.0 in Q3 2025.